230 related articles for article (PubMed ID: 31605350)
21. ASO Author Reflections: Intramural Metastasis as Dismal Prognostic Factor in Esophageal Squamous Cell Carcinoma.
Ushimaru Y; Makino T; Doki Y
Ann Surg Oncol; 2023 Aug; 30(8):5203-5204. PubMed ID: 37285094
[No Abstract] [Full Text] [Related]
22. ASO Author Reflections: Prognostic Role of a Coagulation Index for Patients with Esophageal Squamous Cell Cancer.
Wang Q; Cao B; Mi K
Ann Surg Oncol; 2021 Dec; 28(13):8462-8463. PubMed ID: 34106387
[No Abstract] [Full Text] [Related]
23. ASO Author Reflections: CD36 Expression Is Associated with Cancer Aggressiveness and Energy Source in Esophageal Squamous Cell Carcinoma.
Yoshida T; Yokobori T; Kuriyama K; Sakai M; Sano A; Ogawa H; Sohda M; Saeki H; Kuwano H; Shirabe K
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):791-792. PubMed ID: 32591954
[No Abstract] [Full Text] [Related]
24. ASO Author Reflections: Serum Squamous Cell Carcinoma Antigen in Recurrent Esophageal Squamous Cell Carcinoma.
Kanie Y; Okamura A; Watanabe M
Ann Surg Oncol; 2021 Nov; 28(12):7997-7998. PubMed ID: 33860360
[No Abstract] [Full Text] [Related]
25. ASO Author Reflections: Is Esophagectomy Necessary after Noncurative Endoscopic Resection for Early Esophageal Squamous Cell Carcinoma?
Liu Z; Zhao J; Li Z
Ann Surg Oncol; 2021 Nov; 28(12):7160-7161. PubMed ID: 34263374
[No Abstract] [Full Text] [Related]
26. ASO Author Reflections: Expression and Malignant Potential of B4GALNT4 in Esophageal Squamous Cell Carcinoma.
Baba H; Kanda M; Kodera Y; Fujii T
Ann Surg Oncol; 2020 Sep; 27(9):3257-3258. PubMed ID: 32277319
[No Abstract] [Full Text] [Related]
27. ASO Author Reflections: ANO9 Regulated Cell Cycle in Human Esophageal Squamous Cell Carcinoma.
Katsurahara K; Shiozaki A; Otsuji E
Ann Surg Oncol; 2020 Sep; 27(9):3231-3232. PubMed ID: 32206949
[No Abstract] [Full Text] [Related]
28. ASO Author Reflections: Prediction of the Therapeutic Efficacy in Patients with Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.
Okamura A; Matsuda S; Kawakubo H; Mine S; Takeuchi H; Kitagawa Y; Watanabe M
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):795-796. PubMed ID: 32591950
[No Abstract] [Full Text] [Related]
29. ASO Author Reflections: Involvement of Intracellular and Extracellular High-Mobility Group Box-1 in the Progression of Esophageal Squamous Cell Carcinoma.
Matsubara D; Konishi H; Otsuji E
Ann Surg Oncol; 2020 Sep; 27(9):3245-3246. PubMed ID: 32248372
[No Abstract] [Full Text] [Related]
30. ASO Author Reflections: Appropriate Candidates for Salvage Esophagectomy of Initially Unresectable Locally Advanced T4 Esophageal Squamous Cell Carcinoma.
Booka E; Haneda R; Ishii K; Tsubosa Y
Ann Surg Oncol; 2020 Sep; 27(9):3171-3172. PubMed ID: 32270418
[No Abstract] [Full Text] [Related]
31. ASO Author Reflections: Functional Analysis and Clinical Significance of Chloride Channel 2 Expression in Esophageal Squamous Cell Carcinoma.
Mitsuda M; Shiozaki A; Otsuji E
Ann Surg Oncol; 2021 Sep; 28(9):5398-5399. PubMed ID: 33590362
[No Abstract] [Full Text] [Related]
32. ASO Author Reflections: Esophagectomy or Chemoradiotherapy, That is the Question: Additional Treatment Following Noncurative Endoscopic Resection for Esophageal Squamous Cell Carcinoma.
Kanie Y; Okamura A; Asari T; Ishiyama A; Yoshio T; Tsuchida T; Chin K; Watanabe M
Ann Surg Oncol; 2021 Dec; 28(13):8436-8437. PubMed ID: 34115253
[No Abstract] [Full Text] [Related]
33. ASO Author Reflections: Safety of Elective Esophagectomy Performed on Weekend for Patients with Esophageal Carcinoma.
Yang TY; Chao YK
Ann Surg Oncol; 2023 Jun; 30(6):3799. PubMed ID: 36905439
[No Abstract] [Full Text] [Related]
34. ASO Author Reflections: Serine Protease 27 is a Novel Prognostic Indicator for Esophageal Squamous Cell Carcinoma with Preoperative Treatment.
Kataoka A; Yamada K; Kawamura YI
Ann Surg Oncol; 2021 Sep; 28(9):5382-5383. PubMed ID: 33454876
[No Abstract] [Full Text] [Related]
35. ASO Author Reflections: Expression and Role of CFTR in Human Esophageal Squamous Cell Carcinoma.
Matsumoto Y; Shiozaki A; Otsuji E
Ann Surg Oncol; 2021 Oct; 28(11):6437-6438. PubMed ID: 33710507
[No Abstract] [Full Text] [Related]
36. ASO Author Reflections: Association Between Preoperative Coagulation Status and Prognosis in Patients Undergoing Subtotal Esophagectomy for Esophageal Squamous Cell Carcinoma After Neoadjuvant Treatment.
Sugiyama F; Kanda M; Kodera Y
Ann Surg Oncol; 2024 May; 31(5):3473-3474. PubMed ID: 38261127
[No Abstract] [Full Text] [Related]
37. Lymph node station ratio: Revised nodal category for resected esophageal squamous cell carcinoma patients.
Fu X; Liu Q; Luo K; Wen J; Yang H; Hu Y; Wang X; Lin P; Fu J
J Surg Oncol; 2017 Dec; 116(7):939-946. PubMed ID: 28703872
[TBL] [Abstract][Full Text] [Related]
38. ASO Author Reflections: A Novel, Sensitive, and Effective Index in Predicting Therapeutic Response of Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma.
Feng J; Wang L; Yang X; Chen Q; Cheng X
Ann Surg Oncol; 2024 Jan; 31(1):241-242. PubMed ID: 37838649
[No Abstract] [Full Text] [Related]
39. Nodal skip metastasis in thoracic esophageal squamous cell carcinoma: a cohort study.
Cavallin F; Alfieri R; Scarpa M; Cagol M; Ruol A; Fassan M; Rugge M; Ancona E; Castoro C
BMC Surg; 2017 May; 17(1):49. PubMed ID: 28464907
[TBL] [Abstract][Full Text] [Related]
40. Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection.
Chen J; Wu S; Zheng X; Pan J; Zhu K; Chen Y; Li J; Liao L; Lin Y; Liao Z
BMC Surg; 2014 Dec; 14():110. PubMed ID: 25527100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
